Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Adways Co. Ltd | A02 | Nov 22, 2024 | 1.95 | 0.00 |
ADX Energy Ltd | GHU | Nov 22, 2024 | 0.03 | -10.00 |
ADYEN N.V. EO-,01 | 1N8 | Nov 22, 2024 | 1 293.20 | +4.16 |
Adyen N.V. Unsponsored ADR (Netherlands) | 1N8U | Nov 22, 2024 | 12.70 | +2.42 |
Adyton Resources Corporation | 701 | Nov 22, 2024 | 0.10 | -7.21 |
AECI Ltd | A7Z | Nov 22, 2024 | 4.88 | +0.83 |
AECOM | E6Z | Nov 22, 2024 | 107.00 | +3.88 |
Aecon Group Inc. | 2AE | Nov 22, 2024 | 19.60 | +0.51 |
Aedas Homes S.A.U. | 1QK | Nov 22, 2024 | 24.70 | -0.20 |
Aedifica SA | AOO | Nov 22, 2024 | 55.85 | -1.33 |
Aeffe | 3A1 | Nov 22, 2024 | 0.80 | +0.25 |
AEGA ASA NK 1 | 82T0 | Nov 22, 2024 | 0.02 | +8.99 |
Aegean Airlines S.A. | 32A | Nov 22, 2024 | 9.34 | +0.65 |
Aegirbio | 52Q | Nov 22, 2024 | 0.01 | +1.87 |
Aegis Brands Inc. | 6I9 | Nov 22, 2024 | 0.24 | -8.53 |
AEGON LTD. | J060 | Nov 22, 2024 | 5.94 | +0.47 |
Aegon N.V ADR | J06 | Nov 22, 2024 | 5.90 | +1.72 |
Aehr Test Systems | AYB | Nov 22, 2024 | 10.98 | +2.09 |
Aelis Farma S.A. | 69O | Nov 22, 2024 | 2.78 | -4.79 |
Aemetis, Inc | DW51 | Nov 22, 2024 | 3.85 | +6.59 |
Aena S.M.E. S.A. | A44 | Nov 22, 2024 | 200.20 | +0.20 |
Aena SME S.A. American Depositary Receipts - Unsponsored | A440 | Nov 22, 2024 | 19.10 | +1.06 |
AEON CO. LTD ADR/1 O.N. | JUS | Nov 22, 2024 | 21.80 | 0.00 |
Aeon Co. Ltd. | JUS1 | Nov 22, 2024 | 22.00 | 0.00 |
Aeon Financial Service Co Ltd. | 67J | Nov 22, 2024 | 7.60 | +1.33 |
Aeon Mall Co | 9DH | Nov 22, 2024 | 12.20 | +1.67 |
Aeon Metals Limited | D6V1 | Nov 22, 2024 | 0.00 | 0.00 |
AEON REIT INVESTMEN.CORP. | HB0 | Nov 22, 2024 | 761.70 | +1.41 |
AEON STORES | AVK1 | Nov 22, 2024 | 0.02 | +5.26 |
Aequus Pharmaceuticals Inc | AEQ | Nov 22, 2024 | 0.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.